CD55 antibody (PE)
Quick Overview for CD55 antibody (PE) (ABIN7566577)
Target
See all CD55 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- PE Anti-Human CD55 Antibody[HI55a]
-
Isotype
- IgG2a, kappa
-
-
-
-
Application Notes
-
Each lot of this antibody is quality control tested by flow cytometric analysis. Applications vary, the appropriate dilutions must be determined for individual use.
FCM: 5 µL/test -
Comment
-
Matching Isotype Control: (ABIN7469778)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Phosphate buffered solution, pH 7.2, containing 0.09 % stabilizer and 1 % protein protectant.
-
Storage
- 4 °C
-
Storage Comment
- This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze.
-
Expiry Date
- 12 months
-
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
Alternative Name
- CD55
-
Background
- Complementdecay-acceleratingfactor,CD55,CR,DAF,CD55 is a 60-70 kD glycosylphosphatidylinositol (GPI)-anchored single chain glycoprotein also known as decay-accelerating factor (DAF). It is expressed on hematopoietic cells including erythrocytes and many non-hematopoietic cells. CD55 accelerates the dissociation of the components of the C3-convertases (namely C2a from C4b in the C4bC2a complex, a C3-convertase of the classical pathway, and factor Bb from the C3bBb complex, a C3-convertase of the alternative pathway) to protect cells from inappropriate damage caused by autologous complement. CD55 has been reported to reduce the efficiency of NK cell lysis and induce signal transduction in T cells. CD55 has also been shown to interact with CD97 and bind to Coxsackie and Echovirus.
-
Gene ID
- 1604
-
UniProt
- P13591
-
Pathways
- Complement System, Regulation of Leukocyte Mediated Immunity
Target
-